Qube Research & Technologies LTD Cure Vac N.V. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.75 - $8.5 $71,909 - $106,301	-12,506 Reduced 48.01%	13,542 $81,000
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $360,259 - $734,004	-48,163 Reduced 64.9%	26,048 $205,000
Q2 2022 Aug 15, 2022	BUY	$13.18 - $19.41 $978,100 - $1.44 Million	74,211 New	74,211 $1.01 Million
Q1 2021 May 14, 2021	SELL	$79.79 - $126.29 $280,781 - $444,414	-3,519 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $164,548 - $479,534	3,519 New	3,519 $285,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.